ISRG
Intuitive Surgical, Inc.
—
406.78 $
+4.6000 (%+1.14)
Previous Close: 402.18
Day Low₺400.93
Day High₺409.64
ISRG: Intuitive Surgical, Inc. Financials
ISRG Income Statement
Total revenue
Net income
Gross margin TTM
66%
Operating margin TTM
29.27%
Net profit margin TTM
28.38%
Return on investment TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 10,064,700,000 | 8,352,100,000 | 7,124,100,000 | 6,222,200,000 |
| Operating income | 2,945,500,000 | 2,348,900,000 | 1,766,800,000 | 1,577,100,000 |
| Net income | 2,856,000,000 | 2,322,600,000 | 1,798,000,000 | 1,322,300,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 10,064,700,000 | 8,352,100,000 | 7,124,100,000 | 6,222,200,000 |
| Cost of revenue | 3,422,400,000 | 2,717,900,000 | 2,394,600,000 | 2,026,200,000 |
| Gross profit | 6,642,300,000 | 5,634,200,000 | 4,729,500,000 | 4,196,000,000 |
| Research and development expenses | 1,311,800,000 | 1,145,300,000 | 998,800,000 | 879,000,000 |
| General and administrative expenses | 0 | 0 | 0 | 0 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 2,385,000,000 | 2,140,000,000 | 1,963,900,000 | 1,739,900,000 |
| Other expenses | 0 | 0 | 0 | 0 |
| Operating expenses | 3,696,800,000 | 3,285,300,000 | 2,962,700,000 | 2,618,900,000 |
| Cost and expenses | 7,119,200,000 | 6,003,200,000 | 5,357,300,000 | 4,645,100,000 |
| Net interest income | 365,900,000 | 324,900,000 | 192,100,000 | 29,700,000 |
| Interest income | 365,900,000 | 324,900,000 | 192,100,000 | 29,700,000 |
| Interest expense | 0 | 0 | 0 | 0 |
| Depreciation and amortization | 677,100,000 | 462,000,000 | 402,200,000 | 365,800,000 |
| EBITDA | 3,988,500,000 | 3,135,800,000 | 2,361,100,000 | 1,972,600,000 |
| EBIT | 3,311,400,000 | 2,673,800,000 | 1,958,900,000 | 1,606,800,000 |
| Non-operating income (excl. interest) | -365,900,000 | -324,900,000 | -192,100,000 | -29,700,000 |
| Operating income | 2,945,500,000 | 2,348,900,000 | 1,766,800,000 | 1,577,100,000 |
| Total other income/expenses (net) | 365,900,000 | 324,900,000 | 192,100,000 | 29,700,000 |
| Income before tax | 3,311,400,000 | 2,673,800,000 | 1,958,900,000 | 1,606,800,000 |
| Income tax expense | 434,800,000 | 336,300,000 | 141,600,000 | 262,400,000 |
| Net income from continuing operations | 2,876,600,000 | 2,337,500,000 | 1,817,300,000 | 1,344,400,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 2,856,000,000 | 2,322,600,000 | 1,798,000,000 | 1,322,300,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 2,856,000,000 | 2,322,600,000 | 1,798,000,000 | 1,322,300,000 |
| EPS | 8 | 7 | 5 | 4 |
| Diluted EPS | 8 | 6 | 5 | 4 |
| Weighted average shares outstanding | 356,900,000 | 355,200,000 | 351,200,000 | 355,700,000 |
| Weighted average diluted shares outstanding | 362,700,000 | 362,000,000 | 357,400,000 | 362,000,000 |